Elevance Health
(ELV)Financial Overview
About Elevance Health
Elevance Health, led by CEO Gail Boudreaux, is one of the largest health benefits companies in the U.S., formerly known as Anthem Inc. The company provides medical, pharmacy, and behavioral health plans under brands like Blue Cross Blue Shield. Boudreaux has overseen Elevance’s expansion into whole-health services and data-driven care. It is focused on improving access, affordability, and outcomes across its network. Elevance plays a key role in shaping U.S. managed care.
Analyst Forecast
Elevance Health leverages its scale and Carelon subsidiaries to drive margin expansion and care integration, while maintaining strength in government and commercial health plans. Dividend growth and buybacks remain consistent, but risks are growing around pharmacy benefit manager regulation and pressure on Medicare Advantage margins. With operational efficiency and balanced exposure, it stands as one of the more stable and strategically agile names in managed care.
Analysis by Luigi Wewege
President at Caye International Bank
Luigi Wewege is President of the award-winning Caye International Bank. He is the author of The Digital Banking Revolution, now in its third edition, and of the article “Disruptions and Digital Banking Trends,” published in The Journal of Applied Finance & Banking. Luigi has also co-authored economic research examining the accuracy of credit bureau data, which was presented before the United States Congress. At Caye Bank, his research and strategic insights help guide billions in client portfolio decisions across international markets. Known for his disciplined diversification philosophy, he served as the conceptual architect behind this Portfolio Fit Calculator. He holds an Italian MBA specializing in International Business, and earned his BSBA with a triple major in Finance, International Business, and Management, graduating with Latin Honors from the University of Missouri–St. Louis.
18 years of experience
Should You Buy Elevance Health Stock?
This interactive tool helps you determine whether this stock fits into your investment strategy based on your portfolio size, risk tolerance, and allocation preferences.
What this calculator analyzes:
- Risk compatibility between your profile and this stock
- Appropriate allocation size for your portfolio
- Diversification recommendations
- P/E ratio context and valuation analysis
Example Analysis:
A 11.12 P/E ratio indicates this stock appears undervalued. With a Medium risk rating, this stock may suit moderate risk tolerance.
⚠️ This tool is for informational purposes only. It does not constitute financial advice. Investing involves risk, including loss of capital. Always consult a licensed financial advisor before making investment decisions.